A therapeutic strategy against the shared virulence mechanism utilized by both Yersinia pestis and Pseudomonas aeruginosa

Anesthesiology Clinics of North America

Volumn 22, Issue 3, 2004, Pages 591-606

  Sawa, Teiji ^a   Wiener Kronish, Jeanine P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIAL VACCINE;

BACTERIAL GENOME; BACTERIAL VIRULENCE; BIOLOGICAL WARFARE; CLINICAL FEATURE; CORRELATION ANALYSIS; DRUG EFFICACY; ESCHERICHIA COLI; EUKARYOTIC CELL; GENE TRANSFER; GENE TRANSLOCATION; HUMAN; IMMUNOTHERAPY; NONHUMAN; PASSIVE IMMUNIZATION; PATHOGENESIS; PLAGUE; PNEUMONIA; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA; SHIGELLA; TECHNIQUE; TREATMENT PLANNING; YERSINIA PESTIS;

AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; BIOTERRORISM; HUMANS; IMMUNOTHERAPY; MOLECULAR SEQUENCE DATA; PORE FORMING CYTOTOXIC PROTEINS; PSEUDOMONAS AERUGINOSA; VIRULENCE; YERSINIA PESTIS;

EID: 4344638359     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atc.2004.05.002     Document Type: Review

References (63)

1. NIAID biodefense research agenda for CDC category A agents. National Institutes of Health, National Institute of Allergy and Infectious Diseases 2002. p. 1-55
2. Cornelis G.R., Wolf-Watz H. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol Microbiol. 23:1997;861-867
3. Cornelis G.R. Molecular and cell biology aspects of plague. Proc Natl Acad Sci USA. 97(16):2000;8778-8783
4. Cornelis G.R. Yersinia type III secretion: send in the effectors. J Cell Biol. 158(3):2002;401-408
5. Hueck C.J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev. 62(2):1998;379-433
6. Galan J.E., Collmer A. Type III secretion machines: bacterial devices for protein delivery into host cells. Science. 284(5418):1999;1322-1328
7. Cornelis G.R. The Yersinia Ysc-Yop 'type III' weaponry. Nat Rev Mol Cell Biol. 3(10):2002;742-752
8. Salyers A.A., Whitt D.D. Pseudomonas aeruginosa. Salyers A.A., Whitt D. Bacterial pathogenesis: a molecular approach. 1994;260-270 American Society for Microbiology Press, Washington, DC
9. 2+ -response plasmid pCD1 of Yersinia pestis KIM5. Infect Immun. 66(10):1998;4611-4623
10. Cornelis G.R., Boland A., Boyd A.P., Geuijen C., Iriarte M., Neyt C., et al. The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev. 62:1998;1315-1352
11. 2+-blind mutants of Yersinia pestis. J Bacteriol. 164:1985;704-711
12. Une T., Brubaker R.R. Roles of V antigen in promoting virulence and immunity in Yersiniae. J Immunol. 133:1984;2226-2230
13. Tamano K., Aizawa S., Katayama E., Nonaka T., Imajoh-Ohmi S., Kuwae A., et al. Supramolecular structure of the Shigella type III secretion machinery: the needle part is changeable in length and essential for delivery of effectors. EMBO J. 19(15):2000;3876-3887
14. Hoiczyk E., Blobel G. Polymerization of a single protein of the pathogen Yersinia enterocolitica into needles punctures eukaryotic cells. Proc Natl Acad Sci USA. 98(8):2001;4669-4674
15. Kubori T., Matsushima Y., Nakamura D., Uralil J., Lara-Tejero M., Sukhan A., et al. Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science. 280(5363):1998;602-605
16. Aizawa S.I. Bacterial flagella and type III secretion systems. FEMS Microbiol Lett. 202(2):2001;157-164
17. Heyland D.K., Cook D.J., Griffith L., Keenan S.P., Brun-Buisson C. for the Canadian Critical Trials Group The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient [Pt 1]. Am J Respir Crit Care Med. 159:1999;1249-1256
18. Brun-Buisson C., Doyon F., Carlet J., Dellamonica P., Gouin F., Lepoutre A., et al. for the French ICU Group for Severe Sepsis Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA. 274(12):1995;968-974
19. Nicas T.I., Iglewski B.H. The contribution of exoproducts to virulence of Pseudomonas aeruginosa. Can J Microbiol. 31(4):1985;387-392
20. Roy-Burman A., Savel R.H., Racine S., Swanson B.L., Revadigar N.S., Fujimoto J., et al. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis. 183(12):2001;1767-1774
21. Feltman H., Schulert G., Khan S., Jain M., Peterson L., Hauser A.R. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiol. 147(Pt 10):2001;2659-2669
22. Hauser A.R., Cobb E., Bodi M., Mariscal D., Valles J., Engel J.N., et al. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med. 30(3):2002;521-528
23. Schulert G.S., Feltman H., Rabin S.D., Martin C.G., Battle S.E., Rello J., et al. Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. J Infect Dis. 188(11):2003;1695-1706
24. Wiener-Kronish J., Frank D., Sawa T. Mechanisms of lung epithelial cell injury by acute Pseudomonas aeruginosa. Clark R.S.B., Carcillo A.A. Molecular biology of acute lung injury. 2001;149-161 Kluwer Academic Publishers, Boston
25. Kudoh I., Wiener-Kronish J.P., Hashimoto S., Pittet J.F., Frank D. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am J Physiol. 267(5 Pt 1):1994;L551-L556
26. Fleiszig S.M., Wiener-Kronish J.P., Miyazaki H., Vallas V., Mostov K.E., Kanada D., et al. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun. 65(2):1997;579-586
27. Sawa T., Yahr T.L., Ohara M., Kurahashi K., Gropper M.A., Wiener-Kronish J.P., et al. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med. 5(4):1999;392-398
28. Sawa T., Ohara M., Kurahashi K., Twining S.S., Frank D.W., Doroques D.B., et al. In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections. Infect Immun. 66(7):1998;3242-3249
29. Finck-Barbancon V., Goranson J., Zhu L., Sawa T., Wiener-Kronish J.P., Fleiszig S.M., et al. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol. 25(3):1997;547-557
30. Kurahashi K., Kajikawa O., Sawa T., Ohara M., Gropper M.A., Frank D.W., et al. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest. 104(6):1999;743-750
31. Frank D.W. The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol. 26(4):1997;621-629
32. Yahr T.L., MendeMueller L.M., Friese M.B., Frank D.W. Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon. J Bacteriol. 179(22):1997;7165-7168
33. Stover C.K., Pham X.Q., Erwin A.L., Mizoguchi S.D., Warrener P., Hickey M.J., et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 406(6799):2000;959-964
34. Barinaga M. A shared strategy for virulence. Science. 272(5266):1996;1261-1263
35. Groisman E.A., Ochman H. Pathogenicity islands: bacterial evolution in quantum leaps. Cell. 87(5):1996;791-794
36. Burrows T.W., Bacon G.A. The basis of virulence in Pasteurella pestis: an antigen determining virulence. Br J Exp Pathol. 37:1956;481-493
37. Burrows T.W., Bacon G.A. The effects of loss of virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis. Br J Exp Pathol. 39:1958;278-291
38. Motin V.L., Nakajima R., Smirnov G.B., Brubaker R.R. Passive immunity to Yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect Immun. 62:1994;4192-4201
39. Leary S.E.C., Williamson E.D., Griffin K.F., Russell P., Eley S.M., Titball R.W. Active immunization with recombinant V antigen from Yersinia pesitis protects mice against plague. Infect Immun. 63:1995;2854-2858
40. Heath D.G., Anderson G.W.J., Mauro M., Welkos S., Andrews G.P., Adamovicz J., et al. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine. 16:1998;1131-1137
41. Sato K., Nakajima R., Hara F., Une T., Osada Y. Preparation of monoclonal antibody to V antigen from Yersinia pestis. Contrib Microbiol Immunol. 12:1991;225-229
42. Price S.B., Leung K.Y., Barve S.S., Straley S. Molecular analysis of lcrGVH, the V antigen operon of Yersinia pestis. J Bacteriol. 171(10):1989;5646-5653
43. 2+ response virulence genes. J Bacteriol. 173(8):1991;2649-2657
44. Bergman T., Hakansson S., Forsberg A., Norlander L., Macellaro A., Backman A., et al. Analysis of the V antigen lcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence for a regulatory role of LcrH and LcrV. J Bacteriol. 173(5):1991;1607-1616
45. 2+ in Yersinia pestis include structural genes for outer membrane proteins. Infect Immun. 51:1986;445-454
46. 2+ response, and virulence of Yersinia pestis. J Bacteriol. 177:1995;2530-2542
47. Nilles M.L., Fields K.A., Straley S.C. The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG. J Bacteriol. 180:1998;3410-3420
48. Pettersson J., Holmstrom A., Hill J., Leary S., Frithz-Lindsten E., von Euler-Matell A., et al. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol. 32:1999;961-976
49. Holmstrom A., Olsson J., Cherepanov P., Maier E., Nordfelth R., Pettersson J., et al. LcrV is a channel size-determining component of the Yop effector translocon of Yersinia. Mol Microbiol. 39:2001;620-632
50. Nakajima R., Motin V.L., Brubaker R.R. Suppresion of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun. 63:1995;3021-3029
51. Sing A., Rost D., Tvardovskaia N., Roggenkamp A., Wiedemann A., Kirshning C.J., et al. Yersinia V-antigen exploits Toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med. 196:2002;1017-1024
52. 2 in sepsis associated with Pseudomonas aeruginosa. J Immunol. 167:2001;5880-5886
53. Frank D.W., Vallis A., Wiener-Kronish J.P., Roy-Burman A., Spack E.G., Mullaney B.P., et al. Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV. J Infect Dis. 186:2002;64-73
54. Faure K., Fujimoto J., Shimabukuro D.W., Ajayi T., Shime N., Moriyama K., et al. Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model. J Immune Based Ther Vaccines. 1(2):2003;1-9
55. Sawa T., Corry D.B., Gropper M.A., Ohara M., Kurahashi K., Wiener-Kronish J.P. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J Immunol. 159(6):1997;2858-2866
56. Fields K.A., Nilles M.L., Cowan C., Straley S.C. Virulence role of V antigen of Yersinia pestis at the bacterial cell surface. Infect Immun. 67:1999;5395-5408
57. Sarker M.R., Neyt C., Stainier I., Cornelis G.R. The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD. J Bacteriol. 180(5):1998;1207-1214
58. Frithz-Lindsten E., Holmstrom A., Jacobsson L., Soltani M., Olsson J., Rosqvist R., et al. Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis. Mol Microbiol. 29(5):1998;1155-1165
59. 2+ response. J Bacteriol. 179:1997;1307-1316
60. Neyt C., Cornelis G.R. Role of SycD. the chaperone of the Yersinia Yop translocators YopB and YopD. Mol Microbiol. 31:1999;143-156
61. Allmond L.R., Karaca T.J., Nguyen V.N., Nguyen T., Wiener-Kronish J.P., Sawa T. Protein binding between PcrG-PcrV and PcrH-PopB/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa type III secretion system. Infect Immun. 71(4):2003;2230-2233
62. Dacheux D., Goure J., Chabert J., Usson Y., Attree I. Pore-forming activity of type III system-secreted proteins leads to oncosis of Pseudomonas aeruginosa-infected macrophages. Mol Microbiol. 40:2001;76-85
63. Parkhill J., Wren B.W., Thomson N.R., Titball R.W., Holden M.T., Prentice M.B., et al. Genome sequence of Yersinia pestis, the causative agent of plague. Nature. 413(6855):2001;523-527